These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28376659)

  • 21. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
    Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?
    Kopruszinski CM; Vizin R; Watanabe M; Martinez AL; de Souza LHM; Dodick DW; Porreca F; Navratilova E
    J Headache Pain; 2022 Sep; 23(1):126. PubMed ID: 36175828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.
    Dallel R; Descheemaeker A; Luccarini P
    Cephalalgia; 2018 Apr; 38(4):776-785. PubMed ID: 28565942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
    Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of kappa opioid receptors reduces mechanical hyperalgesia and anxiety-like behavior in a rat model of trigeminal neuropathic pain.
    Turnes JM; Araya EI; Barroso AR; Baggio DF; Koren LO; Zanoveli JM; Chichorro JG
    Behav Brain Res; 2022 Jan; 417():113595. PubMed ID: 34592375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the kappa opioid receptor antagonist, norbinaltorphimine, on stress and drug-induced reinstatement of nicotine-conditioned place preference in mice.
    Jackson KJ; McLaughlin JP; Carroll FI; Damaj MI
    Psychopharmacology (Berl); 2013 Apr; 226(4):763-8. PubMed ID: 22526543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.
    Tejeda HA; Hanks AN; Scott L; Mejias-Aponte C; Hughes ZA; O'Donnell P
    Neuropsychopharmacology; 2015 Dec; 40(13):2856-64. PubMed ID: 25971593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation.
    Obara I; Mika J; Schafer MK; Przewlocka B
    Br J Pharmacol; 2003 Oct; 140(3):538-46. PubMed ID: 12970097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
    Ward M; Norman H; D'Souza MS
    Behav Brain Res; 2018 Feb; 338():56-65. PubMed ID: 29037662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.
    Ito H; Navratilova E; Vagnerova B; Watanabe M; Kopruszinski C; Moreira de Souza LH; Yue X; Ikegami D; Moutal A; Patwardhan A; Khanna R; Yamazaki M; Guerrero M; Rosen H; Roberts E; Neugebauer V; Dodick DW; Porreca F
    Brain; 2023 Mar; 146(3):1186-1199. PubMed ID: 35485490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats.
    Sirohi S; Walker BM
    J Neurochem; 2015 Nov; 135(4):659-65. PubMed ID: 26257334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
    Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
    Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
    Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
    J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).
    Guerrero M; Urbano M; Kim EK; Gamo AM; Riley S; Abgaryan L; Leaf N; Van Orden LJ; Brown SJ; Xie JY; Porreca F; Cameron MD; Rosen H; Roberts E
    J Med Chem; 2019 Feb; 62(4):1761-1780. PubMed ID: 30707578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependent regulation of GABA transmission by kappa opioid receptors in the basolateral amygdala of Sprague-Dawley rats.
    Przybysz KR; Werner DF; Diaz MR
    Neuropharmacology; 2017 May; 117():124-133. PubMed ID: 28163104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.